PIM kinase inhibitor compound having a structure as represented by Formula I, and isomers, diastereomers, enantiomers, tautomers, and pharmaceutically acceptable salts thereof. The compounds significantly inhibit the Pim kinase activity and are used to prepare drugs to treat PIM kinase mediated diseases, such as cancers, multi drug resistance, and inflammatory bowel disease. Also provided are methods for preparing and using the compounds represented by Formula I.
本发明提供一种具有如下式I所示结构的
PIM激酶
抑制剂化合物,以及其异构体、对映体、互变异构体、互变异构体和药学上可接受的盐。这些化合物显著抑制
PIm激酶活性,并用于制备用于治疗
PIM激酶介导疾病,如癌症、多药耐药和炎症性肠病的药物。还提供了制备和使用式I所表示的化合物的方法。